Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Chinese Patent Office
US Army

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,072,836

« Back to Dashboard

Which drugs does patent 9,072,836 protect, and when does it expire?

Patent 9,072,836 protects ADLYXIN and is included in one NDA.

This patent has twenty patent family members in fifteen countries.

Summary for Patent: 9,072,836

Title:Drive mechanism for a drug delivery device and drug delivery device
Abstract: A lead screw, a lead screw nut and a drive member are aligned with an axis defining an axial direction and an opposite axial direction. A coupling between the lead screw and the lead screw nut allows a helical movement of the lead screw with respect to the lead screw nut at least in the axial direction. The lead screw is coupled with the drive member, the coupling generating a helical movement of the lead screw with respect to the drive member when the drive member is moved in the axial direction with respect to the lead screw. A dispense stop feature of the lead screw nut and a dispense stop feature of the drive member prevent the generation of the helical movement of the lead screw when a specified end position of the drive member is approached.
Inventor(s): Plumptre; David Aubrey (Worcestershire, GB)
Application Number:13/825,841
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi-aventis Us
SOLUTION;SUBCUTANEOUS208471-001Jul 27, 2016RXYesYes► Subscribe► SubscribeY
Sanofi-aventis Us
SOLUTION;SUBCUTANEOUS208471-002Jul 27, 2016RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 9,072,836

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
10186736Oct 6, 2010
PCT Information
PCT FiledOctober 05, 2011PCT Application Number:PCT/EP2011/067418
PCT Publication Date:April 12, 2012PCT Publication Number: WO2012/045794

International Patent Family for Patent: 9,072,836

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina083300► Subscribe
Australia2011311617► Subscribe
Brazil112013006949► Subscribe
Canada2811953► Subscribe
China103228310► Subscribe
European Patent Office2438951► Subscribe
European Patent Office2624894► Subscribe
Israel225364► Subscribe
Japan2013539677► Subscribe
Japan6042339► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Farmers Insurance
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus